Paper · 42870280
Liquid biopsy in bladder cancer: towards precision oncology.
Chen C and 10 others. J Transl Med, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Liquid biopsy in bladder cancer: towards precision oncology. Papers, record 42870280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42870280
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liquid biopsy in bladder cancer: towards precision oncology.
- Journal
- J Transl Med
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-15
Source PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Urinary Bladder Neoplasms | Major topic |
| Precision Medicine | Major topic |
| Medical Oncology | Major topic |
| Humans | |
| Liquid Biopsy | |
| Neoplastic Cells, Circulating | |
| Biomarkers, Tumor | |
| Circulating Tumor DNA |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Grant No. 7232132 | Natural Science Foundation of Beijing Municipality | PubMed | ||
| Grant No. 2023YFC2507002 | Key Technologies Research and Development Program | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References262
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,317,891 | Circulating tumor cells, disease progression, and survival in metastatic breast cancer. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15317891 | PubMed |
| 2 | 25,171,411 | Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. | Cell | 2014 | https://conductscience.org/library/papers/25171411 | PubMed |
| 3 | 29,848,605 | Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29848605 | PubMed |
| 4 | 34,753,780 | The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA. | Clin Cancer Res | 2022 | https://conductscience.org/library/papers/34753780 | PubMed |
| 5 | 37,559,592 | Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma. | Oncol Lett | 2023 | https://conductscience.org/library/papers/37559592 | PubMed |
| 6 | 36,884,136 | In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer. | Med Oncol | 2023 | https://conductscience.org/library/papers/36884136 | PubMed |
| 7 | 37,673,768 | Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer. | Eur Urol Oncol | 2024 | https://conductscience.org/library/papers/37673768 | PubMed |
| 8 | 37,441,073 | Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming. | Front Immunol | 2023 | https://conductscience.org/library/papers/37441073 | PubMed |
| 9 | 27,699,237 | Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9. | JCI Insight | 2016 | https://conductscience.org/library/papers/27699237 | PubMed |
| 10 | 30,950,571 | Challenges and Opportunities in Cancer Metabolomics. | Proteomics | 2019 | https://conductscience.org/library/papers/30950571 | PubMed |
1 to 10 of 262
See all 262 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42870280
GET https://conductscience.org/api/papers/v1/42870280/references?page=2